Table 1.

Baseline characteristics

Baseline characteristics	n=48
Age (years): median (range)	60.1 (36.1–79.3)
Gender: # (%)
Male	25 (52.1)
Female	23 (47.9)
Race/ethnicity: # (%)
White	33 (68.8)
African-American	7 (14.6)
Asian	3 (6.3)
Hispanic	2 (4.2)
Other*	3 (6.3)
Malignancy stage: # (%)
Metastatic/locally advanced	47 (97.9)
Non-metastatic	1 (2.1)
Corticosteroid regimen: # (%)
Prednisone	29 (60.4)
Methylprednisolone and prednisone	15 (31.3)
Methylprednisolone	2 (4.2)
Dexamethasone and prednisone	1 (2.1)
Dexamethasone, methylprednisolone and prednisone	1 (2.1)
Dosing† (mg/24 hours): median (range)
Prednisone	60 (20–160)
Methylprednisolone	60 (30–190)
Dexamethasone	12 (12–12)

*One each for unknown, multiple, American Indian/Alaska Native.

†Maximum dose at initiation of steroid tapers.